PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors

Clinical trial NCT05233436 · TERMINATED

Trial details

NCT number: NCT05233436
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Gastric Cancer Gastroesophageal Junction Cancer Urothelial Cancer Non Small Cell Lung Cancer Head and Neck Squamous Cell Carcinomas

Start date: 2022-02-24
Primary completion: 2023-10-16
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.